← Open Payments lookup

SIMONE HOLDEN: Open Payments

NPI 1194152264 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,943 in 193 payments from 15 companies in 2025. Trend: 2023 $1,803 · 2024 $8,555 · 2025 $5,943

Food & beverage: $3,434Speaker / faculty: $2,125Consulting: $384
CompanyPaymentsAmount
PFIZER INC.17$2,273
ABBVIE INC.51$681
Celltrion USA Inc.9$627
Salix Pharmaceuticals, a division of Bausch Health US, LLC25$508
Ardelyx, Inc.22$383
Janssen Biotech, Inc.13$368
GENZYME CORPORATION9$299
Takeda Pharmaceuticals U.S.A., Inc.15$234
Regeneron Healthcare Solutions, Inc.14$231
Madrigal Pharmaceuticals4$77

Products named: VELSIPITY, DUPIXENT, XIFAXAN, ZYMFENTRA, IBSRELA, TREMFYA, RINVOQ, ENTYVIO.

Industry payments across PA — which companies pay providers there.